Overall Status

Recruiting (2)

Completed (1)

Terminated (1)

Phase

phase 1 (2)

phase 3 (2)

Sponsor

Academic and Community Cancer Research United (1)

Incyte Corporation (1)

Institut de Recherches Internationales Servier (1)

M.D. Anderson Cancer Center (1)

Collaborator

National Cancer Institute (NCI) (2)

Study Documents

Clinical Study Report (1)

Individual Participant Data Set (1)

Informed Consent Form (1)

Statistical Analysis Plan (1)

Study Protocol (1)

Study-level clinical trial data (1)

Intervention Type

drug (4)

biological (1)

other (1)

Funder Type

Other (3)

Industry (1)

Study Type

Interventional (4)

metastatic cholangiocarcinoma

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced Cholangiocarcinoma, Metastatic Cholangiocarcinoma Trial in Worldwide (AG-120, Placebo)

Completed

Has Results

Advanced Cholangiocarcinoma
Metastatic Cholangiocarcinoma

AG-120
Placebo

Scottsdale, Arizona
+48 more

Dec 20, 2022

Unresectable Cholangiocarcinoma, Metastatic Cholangiocarcinoma Trial in Worldwide (Pemigatinib, Gemcitabine, Cisplatin)

Recruiting

Unresectable Cholangiocarcinoma
Metastatic Cholangiocarcinoma

Pemigatinib
+2 more

Phoenix, Arizona
+212 more

Nov 15, 2022

Advanced Cholangiocarcinoma, Metastatic Cholangiocarcinoma, Unresectable Cholangiocarcinoma Trial in United States (Cisplatin,

Recruiting

Advanced Cholangiocarcinoma
+2 more

Cisplatin
+3 more

Scottsdale, Arizona
+7 more

Jun 24, 2022

Colorectal Adenocarcinoma, Metastatic Cholangiocarcinoma, Metastatic Colorectal Carcinoma Trial in Houston (biological, drug,

Terminated

Colorectal Adenocarcinoma
+12 more

Adoptive Immunotherapy
+4 more

Houston, Texas

M D Anderson Cancer Center

Oct 28, 2020